Parkinson’s Disease - Vitamin D supplementation may help treat non-motor symptoms related to Parkinson's disease
Can't see this email? View it online
   
  Parkinson's Disease  
  The latest Parkinson's disease news from News Medical  
 Estrogen as a Treatment for Parkinson’s DiseaseEstrogen as a Treatment for Parkinson’s Disease
 
It is thought that estrogen may be protective in the Parkinson’s disease is a neurodegenerative disorder clinically characterized by dyskinesia (impairment of movement), resting tremor, bradykinesia (slow movements), dystonia (stiffness of muscles including facial muscles), a stooped posture, drooling, sexual and urinary dysfunction, and in some cases psychiatric symptoms including psychosis, dementia, and depression.
 
   Vitamin D supplementation may help treat non-motor symptoms related to Parkinson's diseaseVitamin D supplementation may help treat non-motor symptoms related to Parkinson's disease
 
In an Acta Neurologica Scandinavia study of 182 patients with Parkinson's disease and 185 healthy controls, patients with Parkinson's disease had significantly lower levels of vitamin D in their blood.
 
   Johns Hopkins researchers reveal why deep brain stimulation improves Parkinson’s symptomsJohns Hopkins researchers reveal why deep brain stimulation improves Parkinson’s symptoms
 
In a new study of seven people with Parkinson’s disease, Johns Hopkins Medicine researchers report evidence that deep brain stimulation using electrical impulses jumpstarts the nerve cells that produce the chemical messenger dopamine to reduce tremors and muscle rigidity that are the hallmark of Parkinson’s disease, and increases feelings of well-being.
 
 Estrogen could be viable treatment option for Parkinson's patients
 
Estrogen could be viable treatment option for Parkinson's patientsBrain-selective estrogen treatment improves the symptoms of Parkinson’s disease in male mice, according to new research published in JNeurosci. These findings may help explain the sex differences in Parkinson’s disease and could lead to estrogen-based treatments.
 
 
 Genetic engineering could open possibilities for patients with Parkinson’s disease
 
Genetic engineering could open possibilities for patients with Parkinson’s diseasePeople with Parkinson’s disease experience loss of dopamine-producing brain cells, leading to tremors, rigidity, bradykinesia, and postural instability, the primary symptoms of the disease.
 
 
 Researchers move closer to new screening technology for early detection of Parkinson's disease
 
Researchers move closer to new screening technology for early detection of Parkinson's diseaseScreening technology to catch Parkinson's disease in its earliest stages could be available within three years, following an agreement between RMIT University and start-up company Jesse Medical.
 
 
 A new kind of testing for patients with Parkinson's disease
 
A new kind of testing for patients with Parkinson's diseaseParkinson's disease is a neurodegenerative disorder that manifests through symptoms such as tremor, slow movements, limb rigidity and gait and balance problems.
 
 
 Research reveals increased inflammatory activity in patients with frontotemporal dementia
 
Research reveals increased inflammatory activity in patients with frontotemporal dementiaRecent research from the University of Eastern Finland revealed increased inflammatory activity in a subgroup of patients with frontotemporal dementia. Increased inflammation was associated with parkinsonism symptoms and more rapid disease progression.